BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is still a very dangerous and life-threatening disease with an extremely heterogeneous course. Older patients and those with comorbidities are at increased risk of death from the disease but young patients can develop potentially lethal complications too. For those reasons, numerous recent studies focus on the analysis of markers associated with early assessment of COVID-19 prognosis. Previous publications provided evidence for the Intensive Care Infection Score (ICIS) as an easy to use tool to assess the risk for bacterial infection in ICU patients based on a combination of haematologic parameters. This study evaluated the performance of ICIS as a prognostic marker of stages of disease in COVID-19 patients. METHODS: A total of 205 COVID-19 patients admitted to the University Hospital Hradec Kralove, Czech Republic, with symptoms of respiratory tract infection and a positive RT-PCR test for SARS-CoV-2 virus were enrolled in this study. Forty-nine patients developed mild COVID-19 symptoms (no oxygen therapy needed), 156 patients developed moderate or severe symptoms (supplemental oxygen therapy or death). RESULTS: ICIS predicted the mild or moderate/severe course with the highest AUC (0.773). The cut-off value (ICIS = 3.5) was selected as the value with the highest Youden index (0.423). The cut-off value could predict a mild or moderate/severe course of the disease with the highest specificity (77.6%) and positive predictive value (90.2%) of all markers used in this study. Sensitivity was 64.7%. CONCLUSION: ICIS is a reliable, cheap, fast and simply interpretable score for the early identification of moderate/severe course of COVID-19 in an early stage of the disease. ICIS> 3 predicts a severe course of the disease with high specificity and positive predictive value.

4th Department of Internal Medicine Haematology University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove Charles University Sokolska 581 Hradec Kralove Czech Republic

Department of Infectious Diseases University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove Charles University Sokolska 581 Hradec Kralove Czech Republic

Pulmonary Department University Hospital Hradec Kralove and Faculty of Medicine Hradec Kralove Charles University Sokolska 581 Hradec Kralove Czech Republic

See more in PubMed

Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. PubMed DOI PMC

Yoshikawa T., Hill T., Li K., Peters C.J., Tseng C.-T.K. Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells. J Virol. 2009;83:3039–3048. doi: 10.1128/JVI.01792-08. PubMed DOI PMC

Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. PubMed DOI PMC

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines n.d. 〈https://www.covid19treatmentguidelines.nih.gov/〉 (accessed May 14, 2021). PubMed

Pranata R., Lim M.A., Yonas E., Huang I., Nasution S.A., Setiati S., et al. Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis. Epidemiol Infect. 2021:149. doi: 10.1017/S0950268821000236. PubMed DOI PMC

Asghar MS, Haider Kazmi SJ, Khan NA, Akram M., Jawed R., Rafaey W., et al. Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis. Cureus n.d.;12. 〈https://doi.org/10.7759/cureus.10054〉. PubMed PMC

Biji A., Khatun O., Swaraj S., Narayan R., Rajmani R., Sardar R., et al. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples. Microbiology. 2021 doi: 10.1101/2021.02.18.431825. PubMed DOI PMC

Huang I., Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. J Intensive Care. 2020;8 doi: 10.1186/s40560-020-00453-4. PubMed DOI PMC

Liu J., Liu Y., Xiang P., Pu L., Xiong H., Li C., et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18:206. doi: 10.1186/s12967-020-02374-0. PubMed DOI PMC

Taneri P.E., Gómez-Ochoa S.A., Llanaj E., Raguindin P.F., Rojas L.Z., Roa-Díaz Z.M., et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35:763–773. doi: 10.1007/s10654-020-00678-5. PubMed DOI PMC

Huang I., Pranata R., Lim M.A., Oehadian A., Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14 doi: 10.1177/1753466620937175. PubMed DOI PMC

Liu F., Li L., Xu M., Wu J., Luo D., Zhu Y., et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127 doi: 10.1016/j.jcv.2020.104370. PubMed DOI PMC

Izcovich A., Ragusa M.A., Tortosa F., Lavena Marzio M.A., Agnoletti C., Bengolea A., et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15 doi: 10.1371/journal.pone.0241955. PubMed DOI PMC

Nierhaus A., Linssen J., Wichmann D., Braune S., Kluge S. Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS) Inflamm Allergy Drug Targets. 2012;11:109–115. doi: 10.2174/187152812800392841. PubMed DOI

Weimann K., Zimmermann M., Spies C.D., Wernecke K.-D., Vicherek O., Nachtigall I., et al. Intensive Care Infection Score – A new approach to distinguish between infectious and noninfectious processes in intensive care and medicosurgical patients. J Int Med Res. 2015;43:435–451. doi: 10.1177/0300060514557711. PubMed DOI

van der Geest P.J., Mohseni M., Linssen J., Duran S., de Jonge R., Groeneveld A.B.J. The intensive care infection score - a novel marker for the prediction of infection and its severity. Crit Care. 2016;20:180. doi: 10.1186/s13054-016-1366-6. PubMed DOI PMC

Core Team R. R Foundation for Statistical Computing,; Vienna, Austria: 2018. R: A Language and Environment for Statistical Computing.

Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C., et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinforma. 2011;12:77. PubMed PMC

Tape TG. Interpreting Diagnostic Tests, 2021. 〈http://gim.unmc.edu/dxtests/〉 (accessed May 14, 2021).

CDC. CDC Works 24/7. Centers for Disease Control and Prevention, 2021. 〈https://www.cdc.gov/index.htm〉 (accessed June 29, 2021).

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. PubMed DOI PMC

WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020 2020. 〈https://www.who.int/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020〉 (accessed 22 June 2021).

Linssen J., Ermens A., Berrevoets M., Seghezzi M., Previtali G., van der Sar-van der Brugge S., et al. A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study. Elife. 2020;9 doi: 10.7554/eLife.63195. PubMed DOI PMC

Rapid triage and transfer system for patients with proven Covid-19 at emergency department